UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

On the way to find a cure: Purging latent HIV-1 reservoirs

Biochemical pharmacology, 2017-12, Vol.146, p.10-22

2017

Volltextzugriff (PDF)

Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing

The EMBO journal, 2007-01, Vol.26 (2), p.412-423

2007

Volltextzugriff (PDF)

Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity

Journal of proteome research, 2020-09, Vol.19 (9), p.3792-3806

2020

Volltextzugriff (PDF)

Diligent Design Enables Antibody-ASO Conjugates with Optimal Pharmacokinetic Properties

Bioconjugate chemistry, 2023-11, Vol.34 (11), p.2096-2111

2023

Volltextzugriff (PDF)

CTIP2 is a negative regulator of P-TEFb

Proceedings of the National Academy of Sciences - PNAS, 2013-07, Vol.110 (31), p.12655-12660

2013

Volltextzugriff (PDF)

Development and characterization of dendritic cell internalization and activation assays contributing to the immunogenicity risk evaluation of biotherapeutics

Frontiers in immunology, 2024-08, Vol.15, p.1406804

2024

Volltextzugriff (PDF)

Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicity

Frontiers in immunology, 2024-08, Vol.15, p.1406643

2024

Volltextzugriff (PDF)

Genome-wide binding map of the HIV-1 Tat protein to the human genome

PloS one, 2011-11, Vol.6 (11), p.e26894-e26894

2011

Volltextzugriff (PDF)

HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes

Journal of leukocyte biology, 2010-04, Vol.87 (4), p.575-588

2010

Volltextzugriff (PDF)

Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes

Biology (Basel, Switzerland), 2023-09, Vol.12 (9), p.1265

2023

Volltextzugriff (PDF)

Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics

Pharmaceutics, 2022-12, Vol.14 (12), p.2672

2022

Volltextzugriff (PDF)

D-Cateslytin, a new antimicrobial peptide with therapeutic potential

Scientific reports, 2017-11, Vol.7 (1), p.15199-12, Article 15199

2017

Volltextzugriff (PDF)

Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites

Scientific reports, 2017-03, Vol.7 (1), p.43221-43221, Article 43221

2017

Volltextzugriff (PDF)

Improving combination antiretroviral therapy by targeting HIV-1 gene transcription

Expert opinion on therapeutic targets, 2016-11, Vol.20 (11), p.1311-1324

2016

Volltextzugriff (PDF)

Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells

Journal of leukocyte biology, 2003-11, Vol.74 (5), p.736-749

2003

Volltextzugriff (PDF)

In Trauma Patients, the Occurrence of Early-Onset Nosocomial Infections is Associated With Increased Plasma Concentrations of Chromogranin A

Shock (Augusta, Ga.), 2018-05, Vol.49 (5), p.522-528

2018

Volltextzugriff (PDF)

Cateslytin, a chromogranin A derived peptide is active against Staphylococcus aureus and resistant to degradation by its proteases

PloS one, 2013-07, Vol.8 (7), p.e68993-e68993

2013

Volltextzugriff (PDF)

Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injury

Peptides (New York, N.Y. : 1980), 2015-09, Vol.71, p.40-48

2015

Volltextzugriff (PDF)

HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1

Scientific reports, 2016-10, Vol.6 (1), p.34920-34920, Article 34920

2016

Volltextzugriff (PDF)

COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells

Nucleic acids research, 2005-01, Vol.33 (7), p.2318-2331

2005

Volltextzugriff (PDF)

Targeting the Brain Reservoirs: Toward an HIV Cure

Frontiers in immunology, 2016-09, Vol.7, p.397-397

2016

Volltextzugriff (PDF)

A New Combination with D-Cateslytin to Eradicate Root Canal Pathogens

International journal of peptide research and therapeutics, 2019-12, Vol.25 (4), p.1679-1687

2019

Volltextzugriff (PDF)

Interplay between the HTLV-2 Tax and APH-2 proteins in the regulation of the AP-1 pathway

Retrovirology, 2012-12, Vol.9 (1), p.98-98, Article 98

2012

Volltextzugriff (PDF)

Recruitment of Tat to Heterochromatin Protein HP1 via Interaction with CTIP2 Inhibits Human Immunodeficiency Virus Type 1 Replication in Microglial Cells

Journal of Virology, 2003-05, Vol.77 (9), p.5415-5427

2003

Volltextzugriff (PDF)

Correction to “Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity”

Journal of proteome research, 2021-01, Vol.20 (1), p.1103-1103

2021

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(43)

Sprache

Englisch
(39)
Französisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

On the way to find a cure: Purging latent HIV-1 reservoirs

Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing

Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity

Diligent Design Enables Antibody-ASO Conjugates with Optimal Pharmacokinetic Properties

CTIP2 is a negative regulator of P-TEFb

Development and characterization of dendritic cell internalization and activation assays contributing to the immunogenicity risk evaluation of biotherapeutics

Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicity

Genome-wide binding map of the HIV-1 Tat protein to the human genome

HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes

Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes

Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics

D-Cateslytin, a new antimicrobial peptide with therapeutic potential

Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites

Improving combination antiretroviral therapy by targeting HIV-1 gene transcription

Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells

In Trauma Patients, the Occurrence of Early-Onset Nosocomial Infections is Associated With Increased Plasma Concentrations of Chromogranin A

Cateslytin, a chromogranin A derived peptide is active against Staphylococcus aureus and resistant to degradation by its proteases

Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injury

HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1

COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells

Targeting the Brain Reservoirs: Toward an HIV Cure

A New Combination with D-Cateslytin to Eradicate Root Canal Pathogens

Interplay between the HTLV-2 Tax and APH-2 proteins in the regulation of the AP-1 pathway

Recruitment of Tat to Heterochromatin Protein HP1 via Interaction with CTIP2 Inhibits Human Immunodeficiency Virus Type 1 Replication in Microglial Cells

Correction to “Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity”

Suchergebnisse filtern